Bio-pharmaceutical company , XenoPort, Inc. (XNPT), on Wednesday reported fourth-quarter net income of $3.0 million or $0.07 per share, compared to a net loss of $16.9 million or $0.48 per share in the comparable quarter last year.
Total revenues for the latest fourth-quarter were $0.4 million, compared to $5.38 million a year ago.
On average, analysts polled by Thomson Reuters expected a loss of $0.41 per share and revenues of $1.02 million for the fourth quarter. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.